| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/25/2001 | CN1304748A Medicine for treating pile |
| 07/25/2001 | CN1304731A Exterior-applied Chinese patent medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer |
| 07/25/2001 | CN1304727A Injection containing evericin or ivermectin and using benzyl benzoate or nitrone as co-solvent |
| 07/25/2001 | CN1304726A Application of peimin A in preparing medicine to treat drug-resistant bacterial infective diseases |
| 07/25/2001 | CN1304725A Antibacterial cephalosporin composition |
| 07/25/2001 | CN1304724A Composition for preventing and treating osteoporosis and cancer and decreasing blood fat and its application |
| 07/25/2001 | CN1304723A Tanshinone compounds containing dihydrofuran ring structure used for medicine to treat hepatic encephalopathy |
| 07/25/2001 | CN1304722A Medicinal composition for treating AIDS and its application |
| 07/25/2001 | CN1304721A Anti-AIDS medicine composition and its application |
| 07/25/2001 | CN1304713A Oil in polyol type warm substrate |
| 07/25/2001 | CN1068882C Process for preparation of 5-(alkoxymethyl)-2,3-pyridinedicarboximide compounds |
| 07/25/2001 | CN1068881C Phenyl-oxo-alkyl-(4-pieridinyl) benzoate derivs |
| 07/25/2001 | CN1068880C N-substituted piperidingl bicyclic benzoate derivatives |
| 07/25/2001 | CN1068879C Dihydrobenzofuranes |
| 07/25/2001 | CN1068878C Sulfonamide derivatives of azolones anti-helicobacter agents |
| 07/25/2001 | CN1068876C Process for preparing chiral succinic acid derivatives |
| 07/25/2001 | CN1068790C Medicinal composition containing total saponin extracted from stem and leaves of Americam ginseng |
| 07/25/2001 | CN1068778C Drag composition for treating and curing and its preparing method |
| 07/25/2001 | CN1068777C Medical use of 5-hydroxymethyl-2-furol |
| 07/25/2001 | CA2331650A1 Ocular tissue regeneration inducer |
| 07/24/2001 | US6266622 Nuclear receptor ligands and ligand binding domains |
| 07/24/2001 | US6265612 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect |
| 07/24/2001 | US6265610 Contrast media for angiography |
| 07/24/2001 | US6265604 (R)-3-hydroxy-3-(2-phenylethyl)-hexanoic acid derivatives |
| 07/24/2001 | US6265588 Use as pharmaceuticals; as an antigen for production of antibodies and in diagnosis and purification |
| 07/24/2001 | US6265587 Intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor |
| 07/24/2001 | US6265583 Cyclic sulfone containing retroviral protease inhibitors |
| 07/24/2001 | US6265581 Reacting specified epoxide and amine, reacting product with acid to form acid addition salt |
| 07/24/2001 | US6265578 Matrix metalloprotease inhibitors |
| 07/24/2001 | US6265575 Thrombin inhibitors |
| 07/24/2001 | US6265563 Nucleotide sequences probes for use as diagnostic tools and drug screening |
| 07/24/2001 | US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects |
| 07/24/2001 | US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects |
| 07/24/2001 | US6265559 Peptide nucleic acid synthons which have protecting groups which are orthogonal; allows removal of protecting groups under mild conditions; for pna-dna chimeras |
| 07/24/2001 | US6265543 Polypeptide for the treatment of eye disorders, tumors, cancer, psoriasis, trauma, psychological, burns and ulcers |
| 07/24/2001 | US6265540 Peptide having specific amino acid sequence which is cleavage site for prostate specific antigen proteolytic activity; antiproliferative agents |
| 07/24/2001 | US6265537 Thiodepsipeptides for combating endoparasites and a method for producing the same |
| 07/24/2001 | US6265536 Cyclic hexapeptides having antibiotic activity |
| 07/24/2001 | US6265450 Administering astexanthin |
| 07/24/2001 | US6265449 Aqueous compositions comprising ranitidine and LCMT sucrose |
| 07/24/2001 | US6265448 administering toremifene |
| 07/24/2001 | US6265446 Antiinflammatory agents; autoimmune diseases |
| 07/24/2001 | US6265445 Cardiovascular disorders |
| 07/24/2001 | US6265444 Ophthalmic composition |
| 07/24/2001 | US6265443 Method for treating neuronal injury with carboxyfullerene |
| 07/24/2001 | US6265442 Treatment of neurological diseases by increasing brain concentrations of kynurenic acid |
| 07/24/2001 | US6265441 Nitric oxide synthase inhibitor |
| 07/24/2001 | US6265437 Alcoholism |
| 07/24/2001 | US6265436 Substituted 5-biphenyl-3,4-dihydroxy-2(5H)-furanones and method of use therefor |
| 07/24/2001 | US6265435 Topical applying loop diuretic in aqueous solution |
| 07/24/2001 | US6265434 Antiinflammatory agents |
| 07/24/2001 | US6265433 LTA4 hydrolase inhibitors |
| 07/24/2001 | US6265432 Flourine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/24/2001 | US6265431 Cycloalkano-indole and -azaindole derivatives |
| 07/24/2001 | US6265429 Administering phosphodiesrterase inhibitor |
| 07/24/2001 | US6265428 Vasodilation |
| 07/24/2001 | US6265427 Administering an benzimidazole compound |
| 07/24/2001 | US6265426 Triazole derivatives |
| 07/24/2001 | US6265425 Side effect reduction; retinoic acid metabolism blocking agent |
| 07/24/2001 | US6265423 Skin disorders; anticancer agents |
| 07/24/2001 | US6265422 Anticancer agents; cardiovascular disorders |
| 07/24/2001 | US6265421 Phospholamban inhibitors and a method for increasing coronary flow |
| 07/24/2001 | US6265420 Aftertreatment; sustained release |
| 07/24/2001 | US6265419 Irritable bowel disorder |
| 07/24/2001 | US6265416 Anticoagulants |
| 07/24/2001 | US6265415 Compounds for inhibition of gastric acid secretion |
| 07/24/2001 | US6265414 Treating sleep disorders using desloratadine |
| 07/24/2001 | US6265413 Water solubility; anticarcinogenic agents |
| 07/24/2001 | US6265412 Mixture with antihistamine |
| 07/24/2001 | US6265411 Oxindole derivatives |
| 07/24/2001 | US6265410 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/24/2001 | US6265408 Sulphonamide derivatives and their use in the treatment of CNS disorders |
| 07/24/2001 | US6265405 Triazine compounds for treatment of CNS disorders |
| 07/24/2001 | US6265404 Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants |
| 07/24/2001 | US6265403 Angiogenesis inhibitors |
| 07/24/2001 | US6265401 Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 07/24/2001 | US6265399 Alkylation; cyclization |
| 07/24/2001 | US6265397 Amidino derivatives and their use as thrombin inhibitors |
| 07/24/2001 | US6265396 β-lactam compounds and process for preparing the same |
| 07/24/2001 | US6265395 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 07/24/2001 | US6265393 Continuous coadministration of low doses of an estrogen agent and a progestin agent to maintain an induced state of oligomenorrhea or amenorrhea in an afflicted woman. |
| 07/24/2001 | US6265391 Method for preventing peripheral nerve damage |
| 07/24/2001 | US6265390 Methods for expressing nucleic acid sequences using nucleic acid constructs comprising hypoxia response elements |
| 07/24/2001 | US6265386 In a patient undergoing treatment with an aminoglycoside antibiotic |
| 07/24/2001 | US6265385 Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy |
| 07/24/2001 | US6265384 Non-volatile surfactants, polar organic compounds, non-volatile fatty alcohols, or non-volatile fatty esters, for a time sufficient to trigger the immersion reflex in said ectoparasites |
| 07/24/2001 | US6265383 Hypothalamic inhibitory factor (hif) has a positive inotropic effect in a whole organ preparation, such as an isolated perfused heart. |
| 07/24/2001 | US6265195 Nucleic acid of defined nucleotide sequence which codes for a deoxyribonuclease; for production of enough enzyme for clinical use; diagnosis; treatment of cystic fibrosis, lupus, chronic bronchitis, pneumonia, emphysema, and asthma |
| 07/24/2001 | US6265178 Incubating potential inhibitor with solubilized and purified monoamine oxidase in a buffer solution, adding 1-methyl-4-(1-methyl-2-pyrryl)-1,2,3,6-tetrahydropyridine, determining monoamine oxidase inhibitory activity |
| 07/24/2001 | US6265147 Detecting modulators of brain activity; mix modulator with receptors and detect activation of receptors |
| 07/24/2001 | US6264997 Containing proanthocyanidin and flavonide |
| 07/24/2001 | US6264994 Compositions for treating alzheimer's disease and other amyloidoses |
| 07/24/2001 | US6264991 Administering drug in polymer microsphere |
| 07/24/2001 | US6264990 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity. |
| 07/24/2001 | US6264987 Method for preparing microparticles having a selected polymer molecular weight |
| 07/24/2001 | US6264986 Emulsification, mixing, drying |
| 07/24/2001 | US6264984 Effervescent histamine H2 antagonist composition |
| 07/24/2001 | US6264983 Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| 07/24/2001 | US6264980 Transdermal resorption of active substances from supercooled masses of levulic acid |
| 07/24/2001 | US6264978 Transdermal application system containing acetylsalicylic acid for antithrombotic therapy and cancer prophylaxis |